SEATTLE CHILDREN'S HOSPITAL - Coronavirus Contracts

Contracts Vendors Agencies Categories States

Coronavirus Contracts

Tracking Federal Purchases to Fight the Coronavirus

Home › All Vendors › Vendor ›

SEATTLE CHILDREN'S HOSPITAL

Total Committed Value of Federal Contracts

$7.23M

Total Contracts

Total Actions

Location

Seattle, WA

Recent Contract Actions

Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.

Description	Category	Agency	Signed	Amount Committed
TO SUPPORT ON-GOING STUDIES OF THE EMERGING SARS-COV-2 VARIANTS, SUCH AS HOW THE SPIKE PROTEIN FROM THE VARIANTS OF CONCERN INTERACT WITH ANTIBODIES.	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	June 28, 2021	$311,000
LONGITUDINAL STUDY OF COVID-19 ANTIBODY RESPONSE IN CHILDREN IN SEATTLE WA	Other Basic Research R&D	Centers for Disease Control and Prevention	May 24, 2021	$0
LONGITUDINAL STUDY OF COVID-19 ANTIBODY RESPONSE IN CHILDREN IN SEATTLE WA	Other Basic Research R&D	Centers for Disease Control and Prevention	January 14, 2021	$541,048
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	November 03, 2020	$0
TO SUPPORT ON-GOING STUDIES SPECIFICALLY MICROSCOPE TIME AND SUPPLIES REQUIRED FOR CRYOEM AND INCREASED PROTEIN PRODUCTION AND CRYSTALLOGRAPHY DEMANDS, DETERMINING STRUCTURES OF ANTIBODY-BOUND SPIKE PROTEINS, DRUG SCREENING AGAINST SARS-COV-2 TARGETS	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	July 20, 2020	$236,790
TO APPLY STATE-OF-THE-ART HIGH THROUGHPUT TECHNOLOGIES TO EXPERIMENTALLY CHARACTERIZE THE 3-D ATOMIC STRUCTURE OF PROTEINS OR OTHER MOLECULES THAT PLAY AN IMPORTANT BIOLOGICAL ROLE IN HUMAN PATHOGENS AND INFECTIOUS DISEASES.	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	July 13, 2020	$4,894,054
TO FUND ACTIVITIES ASSOCIATED WITH COVID-19 AND REVISE GOVERNMENT PROPERTY - SCHEDULE II-A.	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	June 17, 2020	$89,115
LONGITUDINAL STUDY OF COVID-19 ANTIBODY RESPONSE IN CHILDREN IN SEATTLE WA	Other Basic Research R&D	Centers for Disease Control and Prevention	June 12, 2020	$809,653
COVID-19. OPTION PERIOD TWO. 04/16/2020-08/31/2020. STRUCTURAL GENOMICS CENTERS FOR INFECTIOUS DISEASES.	Biomedical Applied Research/Exploratory Development R&D	National Institutes of Health	April 16, 2020	$351,959

See this vendor on usaspending.gov ›

About this data

This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.